-
Diagnostics World Roundup | Theranos, the Silicon Valley lab led by Elizabeth Holmes, is valued at $9 billion but the Wall Street Journal reports that the company isn't using its technology for all the tests it offers.
Oct 15, 2015
-
The Verge |
Tim Sullivan, CEO of Ancestry.com, tells The Verge that his company has a larger database of genetic information than 23andMe, and he's prepared to turn it toward tests for estimating genetic disease risks.
Oct 14, 2015
-
Diagnostics World Brief | Kailos Genetics has announced the release of PGxComplete, a comprehensive, full panel, gene-based test offered at $99 through November 30, 2015. The Huntsville, Ala.-based company earlier announced a landmark effort with the HudsonAlpha Institute to offer free BRCA screening to 30-year-old women in Northern Alabama.
Oct 14, 2015
-
UVA Today |
The test, developed by doctors at U.Va. and West Virginia University, gives teens an early warning of future problems, but with plenty of time to change behaviors and lower the risks.
Oct 9, 2015
-
Diagnostics World | The UC Santa Cruz lab of Holger Schmidt has published a pair of papers showing that they can identify viral particles and RNA on a thumbnail-sized chip. The research is based on the field of optofluidics, guiding light through liquid channels etched in tiny silicon devices.
Oct 5, 2015
-
Bio-IT World Stephen Kingsmore and his colleagues at the Center for Pediatric Genomic Medicine at Children’s Mercy in Kansas City, announced 26-hour diagnostic whole genome sequencing in a paper published yesterday in Genomic Medicine, an improvement over the 50-hour whole genome sequencing the group published in 2012. The paper is published just one day after Kingsmore took his new post as President and CEO of the Rady Pediatric Genomics and Systems Medicine Institute at Rady Children’s Hospital in San Diego.
Sep 30, 2015
-
Diagnostics World | This Thursday, the FDA sent a letter to Pathway Genomics warning the company that a newly introduced test, a liquid biopsy to find early-stage cancer in apparently healthy people, has not been clinically validated and could be harmful to public health. The letter not only calls attention to the shaky evidence for this test's accuracy, but also asserts the FDA's authority over a whole category of tests in a regulatory gray area.
Sep 25, 2015
-
Diagnostics World Brief | Brigham and Women’s Hospital announced this morning the launch of the Matchmaker Exchange, a way for the rare disease community to share information and find new connections. Matchmaker Exchange connects databases of genetic information and symptoms that physicians and investigators can “match” with a patient’s rare disease.
Sep 24, 2015
-
Massachusetts General Hospital |
MGH researchers have developed a device that can turns a smartphone camera into a microscope to diagnosis cancer and, in the process, reduce patients' anxiety and improve access to care. The next step is a clinical trial in Africa.
Sep 17, 2015
-
Stanford |
Today NIH launches its Undiagnosed Disease Network under the guidance of heart specialist Euan Ashley. Ashley sat for a Q&A with his home institution's news group.
Sep 16, 2015
-
Diagnostics World Brief | Memorial Sloan Kettering Cancer Center and Illumina this morning announced a collaboration to conduct research studies that are critical to understanding the biology of circulating tumor DNA (ctDNA). The studies aim to inform the development of new strategies to diagnose and monitor cancer and to help establish ctDNA as an important marker in the study and eventual treatment of cancer.
Sep 16, 2015
-
Diagnostics World Brief | Less than a year after NextCODE Health was bought by Chinese services group WuXi PharmaTech, WuXi NextCODE has announced a partnership with the Children’s Hospital of Fudan University (CHFU) to bring genomic testing to clinical use in China for the first time.
Sep 16, 2015
-
Diagnostics World Brief Foundation Medicine today announced the launch of its precision medicine partner program, Precision Medicine Exchange Consortium (PMEC), to facilitate data exchange, advance research, and support education and applications of precision medicine in oncology and molecular pathology.
Sep 15, 2015
-
National Human Genome Research Institute |
In a new analysis, a working group of the Clinical Sequencing Exploratory Research (CSER) Consortium has offered an ethical framework to guide pediatricians in pursuing clinical sequencing studies, interpreting results, and, especially, disclosing findings. The study was posted online today.
Sep 14, 2015
-
Diagnostics World Brief | This morning, Pathway Genomics of San Diego announced the launch of two liquid biopsy tests to detect cancer-related DNA mutations, including one that the company claims is the first liquid biopsy on the market for early detection of cancer in healthy patients.
Sep 9, 2015
-
Diagnostics World | In a large pilot initiative with little precedent, HudsonAlpha and its genetic testing spinoff Kailos plan to offer free or steeply discounted genetic screens for susceptibility to breast cancer to thousands of women in the area of Huntsville, Alabama, including women with no known risk factors for the disease.
Sep 9, 2015
-
National Geographic Phenomena |
The Longitude Prize, brought to American shores at an event in Boston last night, is promising over $12 million for the first individual or organization to create a 30-minute, point-of-care diagnostic to detect antibiotic resistance across multiple species and strains of disease-causing bacteria.
Sep 9, 2015
-
WIRED |
The St. Louis company has pulled up roots and moved to San Francisco to join the Y Combinator tech accelerator, on a hunch that catching circular RNA could make for a multi-purpose diagnostic further upstream than traditional protein- and antibody-based tests.
Sep 8, 2015
-
MedPage Today | Authors of a new paper in JAMA Oncology argue that universal testing for breast cancer-related BRCA mutations offers vanishingly low benefit for the cost — but with several providers finding ways to offer these tests for just a few hundred dollars, that calculation may quickly be due for a revision.
Sep 4, 2015